{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:33:31Z","timestamp":1791876811599,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ebiom.2025.105559","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T21:50:46Z","timestamp":1737409846000},"page":"105559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-0788","authenticated-orcid":false,"given":"Haritha","family":"Desu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Balthazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Daigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Da Cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Cl\u00e9net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Margarido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Levert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canisius","family":"Fantodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tastet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Macaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-8086","authenticated-orcid":false,"given":"Marie-Claude","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Arbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-4782","authenticated-orcid":false,"given":"Catherine","family":"Larochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.105559_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105559_bib2","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/cer-2020-0267","article-title":"Efficacy classification of modern therapies in multiple sclerosis","volume":"10","author":"Samjoo","year":"2021","journal-title":"J\u00a0Comp Eff Res"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105559_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2016.02.001","article-title":"Secondary progression in multiple sclerosis: neuronal exhaustion or distinct pathology?","volume":"39","author":"Larochelle","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ebiom.2025.105559_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fneur.2017.00577","article-title":"Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments","volume":"8","author":"Weideman","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebiom.2025.105559_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1197212","article-title":"Impact of aging on treatment considerations for multiple sclerosis patients","volume":"14","author":"Macaron","year":"2023","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"Lopez-Otin","year":"2023","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105559_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145853","article-title":"Identification of SARS-CoV-2-specific immune alterations in acutely ill patients","volume":"131","author":"Rebillard","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105559_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2217\/epi-2019-0102","article-title":"Different epigenetic clocks reflect distinct pathophysiological features of multiple sclerosis","volume":"11","author":"Theodoropoulou","year":"2019","journal-title":"Epigenomics"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105559_bib10","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1212\/WNL.0000000000207489","article-title":"Evaluation of cell-specific epigenetic age acceleration in people with multiple sclerosis","volume":"101","author":"Maltby","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/ijms25020753","article-title":"Immunosenescence and cytomegalovirus: exploring their connection in the context of aging, health, and disease","volume":"25","author":"Muller","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ebiom.2025.105559_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6675353","article-title":"Cytomegalovirus infection and its relationship with leukocyte telomere length: a cross-sectional study","volume":"2021","author":"Lin","year":"2021","journal-title":"Mediators Inflamm"},{"issue":"6509","key":"10.1016\/j.ebiom.2025.105559_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz6876","article-title":"Determinants of telomere length across human tissues","volume":"369","author":"Demanelis","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105559_bib15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.14336\/AD.2021.0106","article-title":"Systematic review of studies on telomere length in patients with multiple sclerosis","volume":"12","author":"Buhring","year":"2021","journal-title":"Aging Dis"},{"key":"10.1016\/j.ebiom.2025.105559_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104179","article-title":"Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age","volume":"82","author":"Zuroff","year":"2022","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001094","article-title":"Evaluation of age-dependent immune signatures in patients with multiple sclerosis","volume":"8","author":"Eschborn","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105559_bib18","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.1502448","article-title":"Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients","volume":"197","author":"Claes","year":"2016","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"13","key":"10.1016\/j.ebiom.2025.105559_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2025.105559_bib24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.ebiom.2025.105559_bib25","author":"Petersen"},{"key":"10.1016\/j.ebiom.2025.105559_bib26","author":"Hebbali"},{"key":"10.1016\/j.ebiom.2025.105559_bib27","author":"Robinson"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105559_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2796.2000.00678.x","article-title":"Mechanisms behind gender differences in circulating leptin levels","volume":"247","author":"Hellstrom","year":"2000","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ebiom.2025.105559_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105559_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/eurjpc\/zwad197","article-title":"Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: atherosclerosis risk in communities study","volume":"30","author":"Jia","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","article-title":"Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance","volume":"25","author":"Hung","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105559_bib32","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/ATVBAHA.120.314508","article-title":"Sex-specific regulation of inflammation and metabolic syndrome in obesity","volume":"40","author":"Ter Horst","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib33","first-page":"3116","article-title":"Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption","volume":"271","author":"Singer","year":"2024","journal-title":"J\u00a0Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105559_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105559_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ene.13622","article-title":"Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?","volume":"25","author":"Alari-Pahissa","year":"2018","journal-title":"Eur J Neurol"},{"issue":"13","key":"10.1016\/j.ebiom.2025.105559_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105559_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2042-4280-2-6","article-title":"Cytomegalovirus-induced immunopathology and its clinical consequences","volume":"2","author":"Varani","year":"2011","journal-title":"Herpesviridae"},{"issue":"26","key":"10.1016\/j.ebiom.2025.105559_bib39","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105559_bib40","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1111\/ene.14961","article-title":"Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study","volume":"28","author":"Grut","year":"2021","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1179\/016164106X98134","article-title":"Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients","volume":"28","author":"Zivadinov","year":"2006","journal-title":"Neurol Res"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032767","article-title":"CMV infection attenuates the disease course in a murine model of multiple sclerosis","volume":"7","author":"Pirko","year":"2012","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.ebiom.2025.105559_bib43","doi-asserted-by":"crossref","first-page":"44266","DOI":"10.18632\/oncotarget.17863","article-title":"Leflunomide\/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication","volume":"8","author":"Bilger","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1191\/1352458502ms794oa","article-title":"Anti-viral properties of interferon beta treatment in patients with multiple sclerosis","volume":"8","author":"Hong","year":"2002","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105559_bib45","first-page":"2275","article-title":"Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies","volume":"269","author":"Prosperini","year":"2022","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib46","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/JVI.79.6.3873-3877.2005","article-title":"Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production","volume":"79","author":"Taylor","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105559_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1352458519892491","article-title":"The effect of sex on multiple sclerosis risk and disease progression","volume":"26","author":"Voskuhl","year":"2020","journal-title":"Mult Scler"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105559_bib48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","article-title":"Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105559_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00001756-199612200-00036","article-title":"Nerve growth factor levels in normal human sera","volume":"8","author":"Serrano","year":"1996","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105559_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-5728(03)00121-8","article-title":"Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls","volume":"138","author":"Gold","year":"2003","journal-title":"J\u00a0Neuroimmunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-3083.2005.01649.x","article-title":"Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis","volume":"62","author":"Caggiula","year":"2005","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13760-012-0101-6","article-title":"Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia","volume":"112","author":"Konukoglu","year":"2012","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105559_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(02)03222-5","article-title":"Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats","volume":"952","author":"Lorigados Pedre","year":"2002","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105559_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.12.8.1","article-title":"Interleukin-4 plasma levels stratified by sex in intermediate age-related macular degeneration and geographic atrophy","volume":"12","author":"Rajeswaren","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00702-004-0225-9","article-title":"Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"112","author":"Bartosik-Psujek","year":"2005","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105559_bib77","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1871530322666220304214512","article-title":"Serum cytokine levels of systemic Lupus Erythematosus patients in the presence of concomitant cardiovascular diseases","volume":"22","author":"Melamud","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"430","key":"10.1016\/j.ebiom.2025.105559_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao2304","article-title":"Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation","volume":"10","author":"Vogelaar","year":"2018","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.immuni.2024.01.001","article-title":"Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging","volume":"57","author":"Zhou","year":"2024","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105559_bib59","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/1352458518775550","article-title":"Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients","volume":"24","author":"Mills","year":"2018","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib61","first-page":"267","article-title":"Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects","volume":"11","author":"Ashtari","year":"2019","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105559_bib62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-5728(99)00120-4","article-title":"CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis","volume":"99","author":"Padberg","year":"1999","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ebiom.2025.105559_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.966766","article-title":"Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases","volume":"13","author":"Jiao","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105559_bib64","doi-asserted-by":"crossref","first-page":"920","DOI":"10.18632\/aging.100369","article-title":"Roles of FGF signaling in stem cell self-renewal, senescence and aging","volume":"3","author":"Coutu","year":"2011","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105559_bib65","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10571-020-00989-x","article-title":"Epidermal growth factor in the CNS: a beguiling journey from integrated cell biology to multiple sclerosis. An extensive translational overview","volume":"42","author":"Scalabrino","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.ebiom.2025.105559_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2015.04.020","article-title":"Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord","volume":"298","author":"Scalabrino","year":"2015","journal-title":"Neuroscience"},{"issue":"42","key":"10.1016\/j.ebiom.2025.105559_bib67","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.1158-11.2011","article-title":"FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions","volume":"31","author":"Clemente","year":"2011","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2008.02.040","article-title":"Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients","volume":"435","author":"Sarchielli","year":"2008","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105559_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2005.11.006","article-title":"Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings","volume":"243","author":"Su","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105559_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128952","article-title":"Plasma biomarkers discriminate clinical forms of multiple sclerosis","volume":"10","author":"Tejera-Alhambra","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105559_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.01.012","article-title":"High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis","volume":"257","author":"Levy","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105559_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13145","article-title":"Activation of epidermal growth factor receptor signaling mediates cellular senescence induced by\u00a0certain pro-inflammatory cytokines","volume":"19","author":"Shang","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.ebiom.2025.105559_bib71","article-title":"Basic fibroblast growth factor inhibits apoptosis and promotes proliferation of adipose-derived mesenchymal stromal cells isolated from patients with type 2 diabetes by reducing cellular oxidative stress","volume":"2017","author":"Nawrocka","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105559_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10016-003-0004-3","article-title":"bFGF-induced alterations in cellular markers of senescence in growth-rescued fibroblasts from chronic venous ulcer and venous reflux patients","volume":"17","author":"Seidman","year":"2003","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ebiom.2025.105559_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200146","article-title":"Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum","volume":"14","author":"Berek","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105559_bib75","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1474-4422(23)00154-0","article-title":"Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial","volume":"22","author":"Corboy","year":"2023","journal-title":"Lancet Neurol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:59:12Z","timestamp":1741924752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":74,"alternative-id":["S2352396425000039"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105559","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105559"}}